Lubazodone (YM-992 YM-35995) is an antidepressant which was being developed as a treatment for depression and reached phase II clinical trials but was discontinued. It acts as a serotonin reuptake inhibitor and 5-HT2A receptor antagonist.
This page contains content from the copyrighted Wikipedia article "Lubazodone"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.